|
(P336) |
Die Evaluation von zanadio - einer digitalen Gesundheitsanwendung für Menschen mit Adipositas |
| |
|
L. Roth (Leipzig) |
|
(P337) |
Current management of hypercholesterolemia in clinical practice: First insights of the non-interventional implementation study VICTORION-Implement |
| |
|
O. Weingärtner, U. Laufs, S. Lorkowski, B. Rauser, R. Etzl, V. Schettler (Jena, Leipzig, Nürnberg, Göttingen) |
|
(P338) |
Efficacy study Efficacy of a digital secondary prevention program to improve therapy adherence of CAD patients |
| |
|
I. Eckardt, F. Jansen (Bonn) |
|
(P339) |
Entwicklung der Häufigkeit von kardiovaskulären Risikofaktoren in Bezug zu Lipoprotein(a) bei 3868 Teilnehmenden der ELITE Studie nach 1 Jahr Follow-Up |
| |
|
B. Schrader, A. Schmidt, C. Conradi, S. Lüders, B. Vaske, J. Schrader, A. Elsässer (Oldenburg, Cloppenburg) |
|
(P340) |
Evolocumab use in clinical practice in Germany: final data of the HEYMANS study |
| |
|
M. Lehrke, V. Schettler, M. Girndt, U. Fraass, I. Bridges, A. Tabbert-Zitzler, A. Vogt (Aachen, Göttingen, Halle (Saale), München; Cambridge, UK) |
|
(P341) |
Shear wave elastography as a novel ultrasound method in the diagnosis of symptomatic peripheral arterial disease with mediasclerosis |
| |
|
M. Maslarska, S. Piepenburg, C. Hehrlein, G. Freund, K. Kaier (Freiburg im Breisgau) |
|
(P342) |
Relationship between the fat attenuation index and plaque burden in an unselected population undergoing coronary computed tomography angiography |
| |
|
A. Giesen, S. Hagstotz, P. Nunninger, M. Schütz, G. Korosoglou, S. Giusca (Weinheim) |
|
(P343) |
Cardiovascular and Inflammatory Biomarkers for Non-Invasive Assessment of Coronary Artery Disease and Long-Term Mortality in Patients with Suspected Chronic Coronary Syndrome |
| |
|
A. Teren, J. Netto, R. Burkhardt, A. Willenberg, F. Beutner, S. Henger, G. Schuler, H. Thiele, B. Isermann, J. Thiery, M. Scholz, T. Kaiser, für die Studiengruppe: LIFE (Bielefeld, Leipzig, Kiel) |
|
(P344) |
Treatment with bempedoic acid and/or its fixed-dose combination with ezetimibe in primary hypercholesterolaemia/mixed dyslipidaemia patients: baseline characteristics from MILOS study (German cohort) |
| |
|
I. Gouni-Berthold, X. Pintó, K. Parhofer, for the study group: MILOS (Cologne, Munich; Barcelona, ES) |
|
(P345) |
Non-persistence to lipid-lowering therapies in Germany: Barriers and ways forward |
| |
|
W. Koenig, L. Beier, K. Willfeld, I. Gouni-Berthold (München, Nürnberg, Köln) |